Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$242.49 - $301.46 $8,244 - $10,249
-34 Reduced 0.78%
4,330 $1.06 Million
Q2 2022

Jul 22, 2022

BUY
$224.73 - $338.64 $18,427 - $27,768
82 Added 1.91%
4,364 $1.08 Million
Q1 2022

Apr 20, 2022

SELL
$277.25 - $366.29 $91,215 - $120,509
-329 Reduced 7.14%
4,282 $1.42 Million
Q4 2021

Feb 02, 2022

BUY
$300.63 - $371.35 $110,932 - $137,028
369 Added 8.7%
4,611 $1.66 Million
Q3 2021

Nov 01, 2021

SELL
$310.19 - $376.2 $164,090 - $199,009
-529 Reduced 11.09%
4,242 $1.38 Million
Q2 2021

Jul 29, 2021

SELL
$262.71 - $351.17 $44,135 - $58,996
-168 Reduced 3.4%
4,771 $1.49 Million
Q1 2021

Apr 21, 2021

SELL
$285.92 - $355.13 $63,188 - $78,483
-221 Reduced 4.28%
4,939 $1.57 Million
Q4 2020

Feb 01, 2021

BUY
$251.88 - $324.2 $105,285 - $135,515
418 Added 8.81%
5,160 $1.67 Million
Q3 2020

Oct 29, 2020

SELL
$255.22 - $317.0 $43,387 - $53,890
-170 Reduced 3.46%
4,742 $1.31 Million
Q2 2020

Aug 04, 2020

SELL
$141.4 - $257.09 $7,070 - $12,854
-50 Reduced 1.01%
4,912 $1.19 Million
Q1 2020

Apr 24, 2020

BUY
$130.51 - $196.01 $22,839 - $34,301
175 Added 3.66%
4,962 $720,000
Q4 2019

Jan 29, 2020

SELL
$159.31 - $223.54 $21,347 - $29,954
-134 Reduced 2.72%
4,787 $817,000
Q3 2019

Oct 28, 2019

SELL
$175.89 - $279.23 $7,211 - $11,448
-41 Reduced 0.83%
4,921 $875,000
Q2 2019

Jul 25, 2019

BUY
$250.96 - $284.94 $8,783 - $9,972
35 Added 0.71%
4,962 $1.29 Million
Q1 2019

Apr 29, 2019

SELL
$276.39 - $362.25 $237,142 - $310,810
-858 Reduced 14.83%
4,927 $1.41 Million
Q4 2018

Feb 04, 2019

SELL
$281.08 - $444.25 $86,572 - $136,829
-308 Reduced 5.05%
5,785 $1.88 Million
Q3 2018

Nov 08, 2018

SELL
$354.53 - $449.75 $101,395 - $128,628
-286 Reduced 4.48%
6,093 $2.74 Million
Q2 2018

Jul 19, 2018

BUY
$278.07 - $446.21 $1.77 Million - $2.85 Million
6,379 New
6,379 $2.61 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.